Sertedaki Amalia, Markou Athina, Vlachakis Dimitrios, Kossida Sophia, Campanac Emilie, Hoffman Dax A, Sierra Maria De La Luz, Xekouki Paraskevi, Stratakis Constantine A, Kaltsas Gregory, Piaditis George P, Chrousos George P, Charmandari Evangelia
Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, 'Aghia Sophia' Children's Hospital, Athens, Greece.
Department of Endocrinology and Diabetes Center, 'G. Gennimatas' General Hospital, Athens, Greece.
Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.
Germline mutations of the KCNJ5 gene encoding Kir3·4, a member of the inwardly rectifying K channel, have been identified in 'normal' adrenal glands, patients with familial hyperaldosteronism (FH) type III, aldosterone-producing adenomas (APAs) and sporadic cases of primary aldosteronism (PA).
To present two novel KCNJ5 gene mutations in hypertensive patients without PA, but with Adrenocorticotropic hormone (ACTH)-dependent aldosterone hypersecretion.
Two hypertensive patients without PA, who exhibited enhanced ACTH-dependent response of aldosterone secretion, underwent genetic testing for the presence of the CYP11B1/CYP11B2 chimeric gene and KCNJ5 gene mutations. Genomic DNA was isolated from peripheral white blood cells, and the exons of the entire coding regions of the above genes were amplified and sequenced. Electrophysiological studies were performed to determine the effect of identified mutation(s) on the membrane reversal potentials. Structural biology studies were also carried out.
Two novel germline heterozygous KCNJ5 mutations, p.V259M and p.Y348N, were detected in the two subjects. Electrophysiological studies showed that the Y348N mutation resulted in significantly less negative reversal potentials, suggesting loss of ion selectivity, while the V259M mutation did not affect the Kir3.4 current. In the mutated structural biology model, the N348 mutant resulted in significant loss of the ability for hydrogen bonding, while the M259 mutant was capable of establishing weaker interactions. The CYP11B1/CYP11B2 chimeric gene was not detected.
These findings expand on the clinical spectrum of phenotypes associated with KCNJ5 mutations and implicate these mutations in the pathogenesis of hypertension associated with increased aldosterone response to ACTH stimulation.
在“正常”肾上腺、Ⅲ型家族性醛固酮增多症(FH)患者、醛固酮瘤(APA)及散发性原发性醛固酮增多症(PA)病例中,已发现编码内向整流钾通道成员Kir3·4的KCNJ5基因的种系突变。
呈现两例无PA但有促肾上腺皮质激素(ACTH)依赖性醛固酮分泌增多的高血压患者中的两个新的KCNJ5基因突变。
两名无PA的高血压患者,其醛固酮分泌呈现增强的ACTH依赖性反应,接受了CYP11B1/CYP11B2嵌合基因和KCNJ5基因突变检测。从外周白细胞中分离基因组DNA,对上述基因整个编码区的外显子进行扩增和测序。进行电生理研究以确定所鉴定突变对膜反转电位的影响。还开展了结构生物学研究。
在两名受试者中检测到两个新的种系杂合KCNJ5突变,即p.V259M和p.Y348N。电生理研究表明,Y348N突变导致反转电位显著降低负值,提示离子选择性丧失,而V259M突变不影响Kir3.4电流。在突变的结构生物学模型中,N348突变体导致氢键形成能力显著丧失,而M259突变体能够建立较弱的相互作用。未检测到CYP11B1/CYP11B2嵌合基因。
这些发现扩展了与KCNJ5突变相关的临床表型谱,并提示这些突变与ACTH刺激下醛固酮反应增加相关的高血压发病机制有关。